WINT insider filings

WINDTREE THERAPEUTICS INC /DE/ — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-10-09. Screen WINT transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for WINT between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — WINDTREE THERAPEUTICS INC /DE/

FiledFormInsiderReported transactionsSource
2024-10-094Fraser Craig — President and CEO, DirectorPurchase (P): 5,431 @ $0.91EDGAR
2024-07-244Simonson Steven — SVP, Chief Medical OfficerGrant/award (A): 13 (derivative) · Grant/award (A): 2,674 (derivative)EDGAR
2024-07-244Fraser Craig — President and CEO, DirectorGrant/award (A): 19 (derivative) · Grant/award (A): 4,011 (derivative)EDGAR
2023-09-284Fraser Craig — President and CEO, DirectorPurchase (P): 2,500 @ $1.02EDGAR
2023-09-274Fraser Craig — President and CEO, DirectorPurchase (P): 2,500 @ $0.90EDGAR
2023-08-294Geffken Daniel E. — DirectorGrant/award (A): 2,033 @ $0 · Grant/award (A): 3,050 (derivative) @ $0EDGAR
2023-08-254Williams Leslie J. — DirectorGrant/award (A): 2,033 @ $0 · Grant/award (A): 3,050 (derivative) @ $0EDGAR
2023-08-254Curtis Eric — SVP & COOGrant/award (A): 14,667 @ $0 · Grant/award (A): 22,000 (derivative) @ $0EDGAR
2023-08-254Simonson Steven — SVP, Chief Medical OfficerGrant/award (A): 15,867 @ $0 · Grant/award (A): 23,800 (derivative) @ $0EDGAR
2023-08-254Strobeck Mark — DirectorGrant/award (A): 2,300 @ $0 · Grant/award (A): 3,450 (derivative) @ $0EDGAR
2023-08-254Fraser Craig — President and CEO, DirectorGrant/award (A): 45,867 @ $0 · Grant/award (A): 68,800 (derivative) @ $0EDGAR
2023-08-254SCOTT ROBERT A — DirectorGrant/award (A): 2,033 @ $0 · Grant/award (A): 3,050 (derivative) @ $0EDGAR
2023-04-274Fraser Craig — President and CEO, DirectorPurchase (P): 1,497 @ $1.77EDGAR
2023-04-264Fraser Craig — President and CEO, DirectorPurchase (P): 1,315 @ $1.89EDGAR
2023-03-024CARMAN DIANE — SVP & General CounselTax withholding (F): 99 @ $0EDGAR
2023-03-024Curtis Eric — SVP & COOTax withholding (F): 99 @ $0EDGAR
2023-03-024Simonson Steven — SVP, Chief Medical OfficerTax withholding (F): 100 @ $0EDGAR
2023-03-024Fraser Craig — President and CEO, DirectorTax withholding (F): 334 @ $0EDGAR
2023-02-234Huang James — DirectorOption exercise/expiry (X): 1,112,308 @ $0.14 · Disposition to issuer (D): 275,862 (derivative) @ $0 · Disposition to issuer (D): 275,938 (derivative) @ $0 · Disposition to issuer (D): 498,008 (derivative) @ $0 · Disposition to issuer (D): 62,500 (derivative) @ $0 · Grant/award (A): 1,112,308 (derivative) @ $0 · +2 moreEDGAR
2022-07-274Fraser Craig — President and CEO, DirectorPurchase (P): 2,500 @ $0.38EDGAR
2022-07-264Hamill John P. — SVP & CFOPurchase (P): 3,000 @ $0.37EDGAR
2022-07-264Fraser Craig — President and CEO, DirectorPurchase (P): 2,500 @ $0.37EDGAR
2022-07-054Fraser Craig — President and CEO, DirectorPurchase (P): 4,500 @ $0.43EDGAR
2022-06-304Fraser Craig — President and CEO, DirectorPurchase (P): 7,000 @ $0.42EDGAR
2022-06-094Williams Leslie J. — DirectorGrant/award (A): 5,000 @ $0 · Grant/award (A): 7,500 (derivative) @ $0EDGAR
2022-06-094Huang James — DirectorGrant/award (A): 5,000 @ $0 · Grant/award (A): 7,500 (derivative) @ $0EDGAR
2022-06-094Geffken Daniel E. — DirectorGrant/award (A): 5,000 @ $0 · Grant/award (A): 7,500 (derivative) @ $0EDGAR
2022-06-094SCOTT ROBERT A — DirectorGrant/award (A): 5,000 @ $0 · Grant/award (A): 7,500 (derivative) @ $0EDGAR
2022-03-174Fraser Craig — President and CEO, DirectorPurchase (P): 2,000 @ $0.98EDGAR
2022-03-154Simonson Steven — SVP, Chief Medical OfficerPurchase (P): 5,000 @ $1.00EDGAR
2022-03-154Fraser Craig — President and CEO, DirectorPurchase (P): 3,000 @ $0.98EDGAR
2022-03-074CARMAN DIANE — SVP & General CounselGrant/award (A): 66,300 @ $0 · Grant/award (A): 99,600 (derivative) @ $0EDGAR
2022-03-074Hamill John P. — SVP & CFOGrant/award (A): 66,300 @ $0 · Grant/award (A): 99,600 (derivative) @ $0EDGAR
2022-03-074Curtis Eric — SVP & COOGrant/award (A): 66,300 @ $0 · Grant/award (A): 99,600 (derivative) @ $0EDGAR
2022-03-074Simonson Steven — SVP, Chief Medical OfficerGrant/award (A): 66,300 @ $0 · Grant/award (A): 99,600 (derivative) @ $0EDGAR
2022-03-074Fraser Craig — President and CEO, DirectorGrant/award (A): 166,900 @ $0 · Grant/award (A): 250,400 (derivative) @ $0EDGAR
2022-01-104Center Laboratories, Inc. — 10% ownerOther (J): 3,551,750 @ $0 · Purchase (P): 55,172 @ $7.25 · Purchase (P): 1,239,088 @ $1.60 · Other (J): 0 (derivative) @ $0 · Other (J): 249,004 (derivative) @ $0 · Purchase (P): 55,172 (derivative) @ $0EDGAR
2022-01-104Bioengine Capital Inc. — 10% ownerOther (J): 3,551,750 @ $0 · Purchase (P): 55,172 @ $7.25 · Sale (S): 1,239,088 @ $1.60 · Other (J): 0 (derivative) @ $0 · Other (J): 249,004 (derivative) @ $0 · Purchase (P): 55,172 (derivative) @ $0EDGAR
2021-11-224Fraser Craig — President and CEO, DirectorPurchase (P): 930 @ $1.60EDGAR
2021-11-184Fraser Craig — President and CEO, DirectorPurchase (P): 930 @ $1.61EDGAR
2021-10-254Fraser Craig — President and CEO, DirectorPurchase (P): 3,000 @ $1.90EDGAR
2021-10-194Huang James — DirectorPurchase (P): 50,000 @ $1.90EDGAR
2021-10-194Fraser Craig — President and CEO, DirectorPurchase (P): 3,000 @ $1.91EDGAR
2021-07-064CARMAN DIANE — SVP & General CounselGrant/award (A): 150,000 (derivative) @ $0EDGAR
2021-06-174Huang James — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2021-06-174Geffken Daniel E. — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2021-04-204Fraser Craig — President and CEO, DirectorPurchase (P): 1,000 @ $2.09EDGAR
2021-04-194Hamill John P. — SVP & CFOPurchase (P): 1,000 @ $2.07EDGAR
2021-04-194Fraser Craig — President and CEO, DirectorPurchase (P): 1,000 @ $2.24EDGAR
2021-04-084Curtis Eric — SVP & COOPurchase (P): 791 @ $2.52EDGAR

Recent 8-K events — WINDTREE THERAPEUTICS INC /DE/

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-07-228-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-078-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2025-12-028-K2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
3.02 — Unregistered Sales of Equity Securities
9.01 — Financial Statements and Exhibits
EDGAR
2025-10-168-K2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
3.02 — Unregistered Sales of Equity Securities
9.01 — Financial Statements and Exhibits
EDGAR
2025-10-068-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2025-09-088-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2025-09-028-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2025-08-208-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2025-08-088-K8.01 — Other EventsEDGAR
2025-08-058-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=WINT returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs